穿戴式心臟設備市場：商業機會、成長要素、產業趨勢分析及2026-2035年預測

全球穿戴式心臟設備市場預計到 2025 年價值 27 億美元，預計到 2035 年將達到 85 億美元，年複合成長率為 12.2%。

全球心血管疾病負擔日益加重、穿戴式健康監測技術的不斷進步以及消費者對微創和非侵入性診斷解決方案日益成長的偏好，共同推動了穿戴式心臟監測設備的市場擴張。此外，健康意識的提高和預防醫學的加速發展也促進了病患群體對這類設備的接受度。穿戴式心臟設備是一種先進的醫療系統，旨在臨床環境之外持續追蹤、診斷和管理心臟相關疾病。這些設備整合了心電圖功能、生物感測器、無線通訊系統和數位訊號處理技術，能夠即時監測心率、心率和其他心血管指標。這有助於及早發現心律不整、心房顫動、缺血性異常和心臟衰竭等疾病，以實現及時的臨床介入。持續監測有助於制定個人化治療方案，減少再入院率，並改善患者的治療效果和生活品質。隨著患者和醫療專業人員越來越傾向於選擇非手術的長期監測方法，以提高診斷效率，同時減少不適感和手術相關風險，對微創心臟監測解決方案的需求不斷成長，進一步推動了市場發展。

到2025年，智慧型手錶市場佔有率將達到28.5%。由於其直覺的介面和易用性，智慧手錶正迅速普及，使用戶無需持續的臨床監測即可自主追蹤心臟健康狀況。這些設備擴大配備先進的感測器系統和基於人工智慧（AI）的分析功能，從而實現持續的即時監測，並為臨床決策提供支援。此外，先進的演算法功能有助於早期發現心律不整，包括心房顫動，並透過及時的警報和干涉措施，幫助降低嚴重心血管併發症的風險。

預計到2025年，冠狀動脈疾病細分市場將佔37.5%的市場佔有率，到2035年將達到33億美元。冠狀動脈疾病仍然是全球最常見的心血管疾病之一，在心臟相關死亡和發生率中佔有相當大的比例。肥胖、缺乏運動、不健康的飲食習慣和吸煙等風險因素的增加加劇了疾病負擔。隨著這些風險因素的持續增加，對持續心臟監測解決方案的需求也在不斷成長，加速了穿戴式心臟裝置在早期檢測和持續疾病管理方面的應用。

預計到2025年，北美穿戴式心臟設備市佔率將達到40.4%。該地區已確立了強勁的市場地位，尤其是在心血管疾病發病率較高的美國。完善的醫療保健體系、先進的醫療基礎設施以及數位健康技術的深度整合，進一步推動了市場成長。現代化醫療設施的普及、優惠的保險報銷政策以及患者健康意識的不斷提高，正在推動全部區域穿戴式心臟設備在早期診斷、遠端監測和長期疾病管理方面的應用。

目錄

第1章：調查方法

• 研究途徑
• 品質改進計劃
  • GMI人工智慧政策和資料完整性計劃
    • 資訊來源一致性協議
• 調查過程和可靠性評分
  • 調查過程的組成部分
  • 評分組成部分
• 數據收集
  • 主要來源部分列表
• 資料探勘資訊來源
  • 付費資訊來源
    • 區域資訊來源
• 基本估算和計算方法
  • 每種方法中基準年的計算
• 預測模型
  • 量化市場影響分析
    • 生長參數對預測的數學影響
• 關於調查透明度的補充信息
  • 資訊來源歸屬框架
  • 品質保證指標
  • 對信任的承諾

第2章執行摘要

第3章業界考察

• 生態系分析
• 影響產業的因素
  • 促進因素
    • 患有心血管疾病的患者人數正在增加。
    • 穿戴式心臟設備技術的快速發展
    • 人們越來越傾向選擇微創設備
    • 健康意識和預防醫學的提高
  • 產業潛在風險與挑戰
    • 資料隱私問題
    • 嚴格的監理政策
  • 市場機遇
    • 家用穿戴式心臟設備的快速普及
    • 與人工智慧和高級分析的整合
• 成長潛力分析
• 監理情勢（基於初步調查）
  • 北美洲
  • 歐洲
  • 亞太地區
• 科技趨勢
  • 當前技術趨勢
    • 連續心電圖（ECG）和貼片式穿戴式心電圖監測設備
    • 雲端整合遠距心電圖監測平台
  • 新興技術
    • 利用非侵入性光學和多模態生物感測進行心臟診斷
    • 一款智慧、互聯、個人化的穿戴式心臟設備。
• 未來市場趨勢（基於初步研究）
• 人工智慧和生成式人工智慧對市場的影響（基於初步研究）
• 2025年價格分析
• 波特五力分析
• PESTEL 分析

第4章 競爭情勢

• 介紹
• 企業市佔率分析
  • 北美洲
  • 歐洲
  • 亞太地區
• 企業矩陣分析
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 合作夥伴關係和合資企業
  • 新產品發布
  • 業務拓展計劃

第5章 市場估價與預測：依產品分類，2022-2035年

• 心電圖監測
• 智慧型手錶
• 修補
• 去心房顫動
• 脈搏血氧飽和度分析儀
• 其他產品

第6章 市場估計與預測：依應用領域分類，2022-2035年

• 冠狀動脈疾病（CAD）
• 心肌病
• 心肌梗塞後
• 先天性心臟疾病
• 術後心臟護理
• 其他用途

第7章 市場估計與預測：依最終用途分類，2022-2035年

• 醫院
• 專業醫療中心
• 居家照護設施
• 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 英國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Abbott Laboratories
• Boston Scientific
• Cardiac Insight
• CardiacSense
• Cardiac Rhythm
• iRhythm Technologies
• Integra LifeSciences
• Koninklijke Philips
• Medtronic
• Proteus Digital Health
• Qardio
• ZOLL Medical Corporation
• Welch Allyn
• VitalConnect
• Zimmer Biomet

The Global Wearable Cardiac Devices Market was valued at USD 2.7 billion in 2025 and is estimated to grow at a CAGR of 12.2% to reach USD 8.5 billion by 2035.

The market expansion is driven by a rising global burden of cardiovascular diseases, continuous advancements in wearable health monitoring technologies, and increasing consumer preference for minimally invasive and non-invasive diagnostic solutions. Growing health awareness and a stronger shift toward preventive healthcare are also reinforcing adoption across patient populations. Wearable cardiac devices are advanced medical systems designed to continuously track, diagnose, and manage heart-related conditions outside clinical environments. These devices integrate electrocardiography capabilities, biosensors, wireless communication systems, and digital signal processing technologies to monitor heart rhythm, heart rate, and other cardiovascular indicators in real time. They enable early identification of conditions such as arrhythmias, atrial fibrillation, ischemic abnormalities, and heart failure, allowing timely clinical intervention. Continuous monitoring supports personalized treatment approaches, reduces hospital readmissions, and improves patient outcomes and quality of life. The rising demand for minimally invasive cardiac monitoring solutions is further strengthening market growth as patients and healthcare providers increasingly prefer non-surgical, long-duration monitoring options that reduce discomfort and procedural risks while improving diagnostic efficiency.

The smartwatches segment accounted for 28.5% share in 2025. This segment is widely adopted due to its intuitive interface and ease of use, enabling individuals to independently track cardiac health without continuous clinical supervision. These devices are increasingly equipped with advanced sensor systems and artificial intelligence based analytics, which allow continuous real-time monitoring and support informed clinical decision-making. Advanced algorithmic capabilities also enhance early detection of abnormal cardiac rhythms, including atrial fibrillation, helping reduce the likelihood of severe cardiovascular complications through timely alerts and interventions.

The coronary artery disease segment held a 37.5% share in 2025 and is expected to reach USD 3.3 billion by 2035. Coronary artery disease remains one of the most prevalent cardiovascular conditions globally and is responsible for a significant proportion of heart-related mortality and morbidity. The increasing prevalence of risk factors such as obesity, sedentary lifestyles, unhealthy dietary habits, and tobacco consumption is contributing to a higher disease burden. As these risk factors continue to rise, demand for continuous cardiac monitoring solutions is increasing, thereby accelerating adoption of wearable cardiac devices for early detection and ongoing disease management.

North America Wearable Cardiac Devices Market accounted for 40.4% share in 2025. The region holds a strong position due to the high incidence of cardiovascular diseases, particularly in the U.S. A well-developed healthcare system, advanced medical infrastructure, and strong integration of digital health technologies further support market growth. Widespread availability of modern healthcare facilities, favorable reimbursement structures, and increasing patient awareness are driving the adoption of wearable cardiac devices for early diagnosis, remote monitoring, and long-term disease management across the region.

Major companies operating in the Global Wearable Cardiac Devices Industry include Medtronic, Abbott Laboratories, Koninklijke Philips, Boston Scientific, iRhythm Technologies, ZOLL Medical Corporation, VitalConnect, Cardiac Insight, CardiacSense, Qardio, Welch Allyn, Cardiac Rhythm, Integra LifeSciences, Zimmer Biomet, and Proteus Digital Health. Companies in the Wearable Cardiac Devices Market are focusing on strengthening their competitive position through continuous innovation in sensor accuracy, device miniaturization, and real-time data analytics capabilities. Significant investments in artificial intelligence and machine learning are enabling enhanced predictive diagnostics and improved patient monitoring outcomes. Firms are also expanding cloud-based connectivity features to ensure seamless data transfer between patients and healthcare providers. Strategic collaborations with hospitals, telehealth platforms, and digital health ecosystems are helping improve product integration and market reach. In addition, companies are prioritizing regulatory compliance and clinical validation to enhance product credibility.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Product trends
  • 2.2.2 Application trends
  • 2.2.3 End use trends
  • 2.2.4 Regional trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number of patients suffering from cardiovascular diseases
    • 3.2.1.2 Rapid technological advancements in wearable cardiac devices
    • 3.2.1.3 Growing preference of minimally invasive devices
    • 3.2.1.4 Rising health consciousness and preventive care
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Data privacy issues
    • 3.2.2.2 Stringent regulatory policies
  • 3.2.3 Market opportunities
    • 3.2.3.1 Rapid expansion of home-use wearable cardiac devices
    • 3.2.3.2 Integration with AI and advanced analytics
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by primary research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
    • 3.5.1.1 Continuous ECG and patch based wearable cardiac monitoring devices
    • 3.5.1.2 Cloud integrated remote cardiac monitoring platforms
  • 3.5.2 Emerging technologies
    • 3.5.2.1 Non invasive optical and multimodal biosensing cardiac diagnostics
    • 3.5.2.2 Smart, connected, and personalized wearable cardiac devices
• 3.6 Future market trends (Driven by primary research)
• 3.7 Impact of AI and Generative AI on the market (Driven by primary research)
• 3.8 Pricing analysis, 2025
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 North America
  • 4.2.2 Europe
  • 4.2.3 Asia Pacific
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Holter monitors
• 5.3 Smartwatches
• 5.4 Patch
• 5.5 Defibrillators
• 5.6 Pulse oximeters
• 5.7 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Coronary artery disease (CAD)
• 6.3 Cardiomyopathies
• 6.4 Post-myocardial infarction
• 6.5 Congenital heart diseases
• 6.6 Post-surgical cardiac care
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Specialty centers
• 7.4 Home care settings
• 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 UK
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Boston Scientific
• 9.3 Cardiac Insight
• 9.4 CardiacSense
• 9.5 Cardiac Rhythm
• 9.6 iRhythm Technologies
• 9.7 Integra LifeSciences
• 9.8 Koninklijke Philips
• 9.9 Medtronic
• 9.10 Proteus Digital Health
• 9.11 Qardio
• 9.12 ZOLL Medical Corporation
• 9.13 Welch Allyn
• 9.14 VitalConnect
• 9.15 Zimmer Biomet